These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 22632829)

  • 21. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary revascularization strategy for ST elevation myocardial infarction with multivessel disease: experience and results at 1-year follow-up.
    Mohamad T; Bernal JM; Kondur A; Hari P; Nelson K; Niraj A; Badheka A; Hassna S; Kiernan T; Elder MD; Gardi D; Schreiber T
    Am J Ther; 2011; 18(2):92-100. PubMed ID: 20027110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of percutaneous coronary intervention and coronary artery bypass grafts for ostial right coronary lesions in propensity-matched individuals.
    Gan HL; Zhang JQ; Huang F; Gu CX; Kong QY; Cao XR; Bo P; Lu CS
    Cardiovasc Ther; 2011 Dec; 29(6):395-403. PubMed ID: 20718758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials.
    Onuma Y; Wykrzykowska JJ; Garg S; Vranckx P; Serruys PW;
    JACC Cardiovasc Interv; 2011 Mar; 4(3):317-23. PubMed ID: 21435610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction.
    Corpus RA; House JA; Marso SP; Grantham JA; Huber KC; Laster SB; Johnson WL; Daniels WC; Barth CW; Giorgi LV; Rutherford BD
    Am Heart J; 2004 Sep; 148(3):493-500. PubMed ID: 15389238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting.
    Xanthopoulou I; Davlouros P; Tsigkas G; Panagiotou A; Hahalis G; Alexopoulos D
    Can J Cardiol; 2011; 27(6):716-24. PubMed ID: 22019279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
    Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
    Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW
    Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
    Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
    Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.
    Brener SJ; Lytle BW; Casserly IP; Ellis SG; Topol EJ; Lauer MS
    Eur Heart J; 2006 Feb; 27(4):413-8. PubMed ID: 16272211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of outcomes of unprotected left main versus multivessel coronary artery interventions.
    Agarwal S; Zaman T; Tuzcu EM; Shishehbor M; Lincoff AM; Whitlow PL; Bajzer C; Franco I; Nair R; Raymond R; Ellis SG; Kapadia SR
    Am J Cardiol; 2011 Jul; 108(1):15-20. PubMed ID: 21529732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry).
    Leitner J; Vlachos HA; Selzer F; Jamal SM; Kip KE; Williams DO; Abbott JD
    Am J Cardiol; 2012 Feb; 109(4):466-70. PubMed ID: 22118825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.